MORGAN ARRINGTON: Open Payments
NPI 1538651716 · SMITHFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$80 in 5 payments from 4 companies in 2025. Trend: 2023 $129 · 2024 $249 · 2025 $80
Food & beverage: $80
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: GEMTESA, Ozempic, MOUNJARO, JARDIANCE.
Industry payments across VA — which companies pay providers there.
